ARS Pharmaceuticals (SPRY)
5.62
-0.05 (0.88%)
Upcoming Events
Latest Headlines
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
September 1, 2026 4:01 PM - StreetInsider
Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
August 25, 2026 7:03 PM - SEC Filing
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar
August 25, 2026 9:09 AM - StreetInsider
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):
August 24, 2026 8:04 AM - StreetInsider
Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
August 20, 2026 5:32 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
August 20, 2026 4:26 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
August 19, 2026 4:21 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
August 19, 2026 4:10 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
August 18, 2026 6:05 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
August 18, 2026 5:38 PM - SEC Filing
Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
August 18, 2026 9:10 AM - StreetInsider
Form 3 ARS Pharmaceuticals, For: Aug 17 Filed by: Smith Margaret Ekins
August 17, 2026 4:45 PM - SEC Filing
Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
August 14, 2026 9:04 AM - StreetInsider
Form 10-Q ARS Pharmaceuticals, For: Jun 30
August 13, 2026 4:08 PM - SEC Filing
Form 8-K ARS Pharmaceuticals, For: Aug 13
August 13, 2026 4:03 PM - SEC Filing
ARS Pharmaceuticals posts $26.2M in Q2 revenue, cuts ad spending
August 13, 2026 4:01 PM - StreetInsider
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
August 13, 2026 4:01 PM - StreetInsider
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of ARS Pharmaceuticals, Inc. (SPRY)
August 13, 2026 7:46 AM - StreetInsider
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
August 3, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: BlackRock, Inc.
July 27, 2026 4:27 PM - SEC Filing
Richard Lowenthal resigns from ARS Pharmaceuticals board
July 17, 2026 4:05 PM - StreetInsider
Form 8-K ARS Pharmaceuticals, For: Jul 15
July 17, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A ARS Pharmaceuticals, Filed by: MILLENNIUM MANAGEMENT LLC
July 14, 2026 5:47 PM - SEC Filing
Form 8-K ARS Pharmaceuticals, For: Jul 06
July 7, 2026 4:39 PM - SEC Filing
ARS Pharmaceuticals names Donn Casale as CEO, replacing co-founder
July 7, 2026 4:30 PM - StreetInsider
ARS Pharmaceuticals Announces CEO Succession
July 7, 2026 4:30 PM - StreetInsider
Form 4 ARS Pharmaceuticals, For: Jul 01 Filed by: Casale Donn
July 2, 2026 4:31 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shah Rajeev M.
June 26, 2026 4:52 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Dadoo Rajeev
June 26, 2026 4:20 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shah Pratik
June 26, 2026 4:16 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Kelly Michael
June 26, 2026 4:16 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shawver Laura
June 26, 2026 4:15 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: SCHNEIDER PHILLIP M
June 26, 2026 4:15 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: SAUNDERS BRENT L
June 26, 2026 4:15 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Islam Saqib
June 26, 2026 4:15 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Thompson Peter A.
June 26, 2026 4:15 PM - SEC Filing
Form 8-K ARS Pharmaceuticals, For: Jun 24
June 25, 2026 5:01 PM - SEC Filing
ARS Pharmaceuticals (SPRY) Reiterated at Overweight by Cantor Fitzgerald
June 25, 2026 7:05 AM - StreetInsider
ARS Pharmaceuticals cuts 2026 expenses after no new neffy coverage gains
June 24, 2026 4:05 PM - StreetInsider
ARS Pharmaceuticals Provides Commercial and Financial Updates
June 24, 2026 4:05 PM - StreetInsider
Form 4 ARS Pharmaceuticals, For: Jun 12 Filed by: Karas Eric
June 12, 2026 8:06 PM - SEC Filing
Form 4 ARS Pharmaceuticals, For: Jun 12 Filed by: Fitzpatrick Alexander A
June 12, 2026 8:05 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Karas Eric
June 12, 2026 4:32 PM - SEC Filing
Form 144 ARS Pharmaceuticals, Filed by: Fitzpatrick Alexander A
June 12, 2026 4:18 PM - SEC Filing
Full Article List
